TherapeuticsMD, Inc.

TXMD Real Time Price USD
N/A
N/A
N/A
...
Overview
Financials
Insiders
Institutions
Government
Ownership

Chart provided by TradingView

Income
Balance Sheet
Cash Flow
TXMD Income Statement
TXMD Balance Sheet
TXMD Cash Flow
Congress Trading

Recent trades of TXMD by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard
TXMD Stock Insider Trading Activity
Name
Type
Shares
Price
Shares Held
Date
Reported
TXMD Stock Institutional Owners
Investor
Shares
Change in Shares
Market Value
Date
Reported
TXMD Derivatives Institutional Owners
Investor
Type
Shares
Change in Shares
Market Value
Date
Reported
Whale Activity

Recently reported changes by institutional investors

Insider Trading

Quarterly net insider trading by TXMD's directors and management

Corporate Lobbying

Government lobbying spending instances

  • $40,000 Jan 19, 2023 Issue: Health Issues
  • $60,000 Oct 19, 2022 Issue: Health Issues
  • $60,000 Jul 20, 2022 Issue: Health Issues
  • $60,000 Apr 20, 2022 Issue: Health Issues
  • $60,000 Jan 20, 2022 Issue: Health Issues
  • $20,000 Oct 20, 2021 Issue: Health Issues
  • $30,000 Jan 20, 2018 Issue: Health Issues
  • $40,000 Jan 18, 2018 Issue: Health Issues
  • $30,000 Oct 19, 2017 Issue: Health Issues
  • $60,000 Oct 18, 2017 Issue: Health Issues
  • $30,000 Jul 20, 2017 Issue: Health Issues
  • $60,000 Jul 20, 2017 Issue: Health Issues
  • $30,000 Apr 20, 2017 Issue: Health Issues
  • $60,000 Apr 19, 2017 Issue: Health Issues
  • $30,000 Jan 19, 2017 Issue: Health Issues
  • $60,000 Jan 18, 2017 Issue: Health Issues
  • $30,000 Oct 27, 2016 Issue: Health Issues
  • $60,000 Oct 20, 2016 Issue: Health Issues
  • $60,000 Jul 19, 2016 Issue: Health Issues
  • $30,000 Jul 06, 2016 Issue: Health Issues
  • $60,000 Apr 20, 2016 Issue: Health Issues
  • $30,000 Apr 20, 2016 Issue: Health Issues
  • $40,000 Jan 21, 2016 Issue: Health Issues
  • $50,000 Jan 20, 2016 Issue: Health Issues
  • $30,000 Oct 21, 2015 Issue: Health Issues
Corporate Lobbying

Estimated quarterly lobbying spending

U.S. Patents

New patents grants

  • Patent Title: Progesterone formulations having a desirable pk profile Jan. 09, 2024
  • Patent Title: Natural combination hormone replacement formulations and therapies Oct. 24, 2023
  • Patent Title: Steroid hormone pharmaceutical formulations Apr. 25, 2023
  • Patent Title: Soluble estradiol capsule for vaginal insertion Apr. 11, 2023
  • Patent Title: Natural combination hormone replacement formulations and therapies Dec. 20, 2022
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Nov. 15, 2022
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Jun. 07, 2022
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Apr. 19, 2022
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Mar. 08, 2022
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Feb. 15, 2022
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Feb. 08, 2022
  • Patent Title: Natural combination hormone replacement formulations and therapies Nov. 09, 2021
  • Patent Title: Soluble estradiol capsule for vaginal insertion Sep. 21, 2021
  • Patent Title: Soluble estradiol capsule for vaginal insertion Sep. 14, 2021
  • Patent Title: Natural combination hormone replacement formulations and therapies Sep. 07, 2021
  • Patent Title: Natural combination hormone replacement formulations and therapies Aug. 31, 2021
  • Patent Title: Soluble estradiol capsule for vaginal insertion Jul. 20, 2021
  • Patent Title: Progesterone formulations having a desirable pk profile Jun. 15, 2021
  • Patent Title: Formulations for solubilizing hormones Feb. 09, 2021
  • Patent Title: Soluble estradiol capsule for vaginal insertion Jan. 12, 2021
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Nov. 17, 2020
  • Patent Title: Natural combination hormone replacement formulations and therapies Oct. 20, 2020
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Oct. 20, 2020
  • Patent Title: Natural combination hormone replacement formulations and therapies Jun. 09, 2020
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Jun. 02, 2020
  • Patent Title: Mold for a medical dosage form Jun. 02, 2020
  • Patent Title: Progesterone formulations May. 05, 2020
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Feb. 25, 2020
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Jan. 21, 2020
  • Patent Title: Steroid hormone pharmaceutical composition Jan. 14, 2020
  • Patent Title: Progesterone formulations having a desirable pk profile Nov. 12, 2019
  • Patent Title: Steroid hormone pharmaceutical composition Nov. 12, 2019
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Nov. 12, 2019
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Sep. 03, 2019
  • Patent Title: Formulations for solubilizing hormones Jun. 25, 2019
  • Patent Title: Steroid hormone compositions in medium chain oils May. 14, 2019
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Apr. 16, 2019
  • Patent Title: Natural combination hormone replacement formulations and therapies Feb. 19, 2019
  • Patent Title: Transdermal cream Oct. 16, 2018
  • Patent Title: Progesterone formulations Aug. 21, 2018
  • Patent Title: Steroid hormone pharmaceutical composition Apr. 03, 2018
  • Patent Title: Pharmaceutical capsule Oct. 31, 2017
  • Patent Title: Depletion of plasma proteins Aug. 16, 2016
  • Patent Title: Natural combination hormone replacement formulations and therapies Apr. 05, 2016
  • Patent Title: Vaginal inserted estradiol pharmaceutical compositions and methods Mar. 22, 2016
  • Patent Title: Transdermal hormone replacement therapies Feb. 02, 2016
  • Patent Title: Soluble estradiol capsule for vaginal insertion Nov. 10, 2015
  • Patent Title: Natural combination hormone replacement formulations and therapies Aug. 25, 2015
  • Patent Title: Natural combination hormone replacement formulations and therapies Aug. 25, 2015
  • Patent Title: Natural combination hormone replacement formulations and therapies Apr. 21, 2015
Government Contracts

Federal grants, loans, and purchases

Government Contracts

Estimated quarterly amount awarded from public contracts

WallStreetBets

Number of mentions of TXMD in WallStreetBets Daily Discussion

TXMD News

Recent insights relating to TXMD

CNBC Recommendations

Recent picks made for TXMD stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in TXMD

TXMD Top Shareholders
Shareholder
Shares Held
TXMD Options Owners
Shareholder
Security
Underlying Shares

* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.

TXMD Stock Smart Score

The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.

The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.
?

Sign Up to view TXMD Smart Score

Score Breakdown
Bull Case vs Bear Case

See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.

Example:

Bulls Say:

The Bulls Say summary highlights positive aspects of the stock.

Bears Say:

The Bears Say summary points out potential risks and negative aspects of the stock.

Show More
Back To Top